Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer

NCT00002734 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Ovarian Cancer
Primary Peritoneal Cavity Cancer

Interventions

BIOLOGICAL: recombinant interferon alfa
DRUG: chemotherapy
DRUG: paclitaxel
DRUG: topotecan hydrochloride
RADIATION: lutetium Lu 177 monoclonal antibody CC49
RADIATION: yttrium Y 90 monoclonal antibody CC49

Sponsor

National Cancer Institute (NCI)